Centers of Excellence to Enhance Disease Detection in Newborns
ID: 349850Type: Posted
Overview

Buyer

Centers for Disease Control - NCEH (HHS-CDC-NCEH)

Award Range

$750K - $1M

Eligible Applicants

Unrestricted

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/349850
Timeline
    Description

    The Centers for Disease Control and Prevention (CDC) is offering a funding opportunity titled "Centers of Excellence to Enhance Disease Detection in Newborns" through a cooperative agreement aimed at improving newborn screening practices. The initiative seeks to establish a Center of Excellence that will develop infrastructure for advanced technologies, optimize screening performance, and incorporate bioinformatics to enhance disease detection in newborns across U.S. states and territories. This program is critical as it leverages innovative technologies to address existing gaps in newborn screening, ultimately aiming to improve public health outcomes for newborns. The estimated total program funding is $4 million, with individual awards ranging from $750,000 to $1 million, and applications are due by June 4, 2024, for a funding period starting September 30, 2024. For further inquiries, interested applicants can contact Cynthia F. Hinton at ceh9@cdc.gov.

    Point(s) of Contact
    ceh9@cdc.gov
    Files
    Title
    Posted
    CDC-RFA-EH24-0044.pdf
    The NOFO (Notice of Funding Opportunity) CDC-RFA-EH24-0044 focuses on establishing a Center of Excellence dedicated to enhancing disease detection in newborns. While a Letter of Intent is optional, it helps CDC staff prepare for application reviews. Only one jurisdiction will receive funding, but collaboration with additional jurisdictions is required. Eligible applicants include public entities; for-profit organizations are excluded. The funding period begins September 30, 2024, with an application deadline of June 4, 2024. Applications must include a comprehensive Project Narrative detailing backgrounds, methodologies, evaluation plans, and work structure, alongside documentation such as resumes and letters of support. A minimum of one support letter is mandatory. Key features of the program include the ED3N data platform, which seeks to modernize newborn screening processes through enhanced data sharing and technological innovations. Successful applicants must conduct pilot programs, ensure thorough evaluations of performance measures, and engage in data management planning. The initiative aims to foster improved screening practices across jurisdictions by utilizing advanced technologies and addressing existing gaps in newborn screening processes.
    Center.pdf
    The document outlines the Notice of Funding Opportunity (NOFO) CDC-RFA-EH24-0044 for the NSMBB Center of Excellence aimed at enhancing disease detection in newborns. It specifies that while a Letter of Intent (LOI) is recommended, it is not mandatory. Only one award will be granted despite partnerships with multiple jurisdictions. For-profit organizations are ineligible to apply. The funding is set to begin on September 30, 2024, with an award date around July 30, 2024. Applicants must provide a comprehensive Project Narrative including topics like background, methods, evaluation plans, and organizational capacity. Grants will not cover equipment purchases but may support lab time through contracts. Evaluation will involve both biochemical and molecular technologies, alongside a Data Management Plan integrated within the application package. Additionally, the document clarifies the role of partner jurisdictions, the use of advanced technologies in newborn screening, and the necessity of a Coordinating Group. The recipient organization will be responsible for evaluating performance measures throughout the four-year period. The initiative reflects the CDC's commitment to improving public health outcomes for newborns through innovative approaches and collaborative partnerships.
    Similar Opportunities
    Advancing the Centers of Excellence in Newcomer Health
    Active
    Centers for Disease Control - NCEZID
    The Centers for Disease Control and Prevention (CDC) is forecasting a funding opportunity titled "Advancing the Centers of Excellence in Newcomer Health," aimed at enhancing health outcomes for immigrants and refugees in the United States. This cooperative agreement seeks innovative approaches to outreach and healthcare analysis for at-risk newcomer populations, focusing on areas such as health surveillance, clinical training, and the development of health orientation materials. With an estimated total program funding of $10 million and an award ceiling of $2 million, the CDC anticipates awarding two grants, with applications due by May 2, 2025. Interested applicants, specifically private institutions of higher education, can reach out to the Domestic Team at the Immigrant & Refugee Health Branch via email at IRHBdomestic@cdc.gov or by phone at 800-232-4636 for further information.
    Enhancing Public Health Surveillance of Bleeding Disorders
    Active
    Centers for Disease Control - NCBDDD
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Enhancing Public Health Surveillance of Bleeding Disorders." This initiative aims to collect and utilize surveillance data from federally supported hemophilia treatment centers to inform policies and clinical practices related to hemophilia, von Willebrand disease, and other inherited bleeding disorders, ultimately seeking to reduce health complications and improve the quality of life for affected individuals. The program is critical for understanding treatment practices, monitoring health complications, and identifying causes of death among those with bleeding disorders. The estimated total program funding is $21.5 million, with individual awards ranging from $100,000 to $4.3 million. Interested applicants can reach out to Brandi Dupervil at (404) 498-6879 or via email at inm4@cdc.gov, with applications due by May 15, 2025, and an anticipated award date of August 31, 2025.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for research titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at developing novel screening techniques and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening. This initiative encourages diverse scientific research focused on improving screening technologies, therapeutic interventions, and preclinical testing, particularly for "high priority" genetic conditions that are not currently recommended for screening but could benefit from early identification and treatment. Eligible applicants include a wide range of organizations, such as educational institutions, community-based organizations, and tribal governments, with applications due by November 5, 2024. For further inquiries, interested parties can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov, and additional details can be found at the provided link: http://grants.nih.gov/grants/guide/pa-files/PAR-21-353.html.
    Epilepsy Incidence Among Children in the United States
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is forecasting a grant opportunity titled "Epilepsy Incidence Among Children in the United States," aimed at understanding the incidence of epilepsy among U.S. children aged 0 to 17 years. The primary objectives include estimating epilepsy incidence using comprehensive nationwide datasets, identifying risk factors associated with developing epilepsy, and examining disparities in incidence rates across various demographics and social determinants of health. This research is crucial for informing public health policies and resource allocation to improve healthcare services for affected populations. The estimated total program funding is $1.6 million, with a maximum award ceiling of $500,000, and interested applicants must submit their proposals by January 23, 2025. For further inquiries, contact Alison Amoroso at aamoroso@cdc.gov or call 470-395-2521.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for innovative research aimed at developing screening approaches and therapies for screenable disorders in newborns, designated as R21 - Clinical Trial Optional. This initiative encourages projects that focus on creating novel screening techniques and therapeutic interventions for potentially fatal or disabling conditions identified through newborn screening, particularly emphasizing early diagnosis and treatment to improve health outcomes. The program is part of NIH's commitment to advancing public health and reducing health disparities, with a funding ceiling of $275,000 available over a two-year period. Interested applicants, including a diverse range of institutions and organizations, must submit their proposals by November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R03 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns," aimed at encouraging research into novel screening methods and therapeutic interventions for serious genetic and congenital conditions identified through newborn screening. This initiative, under the R03 Small Grant Program, supports small-scale projects lasting up to two years with a budget of up to $50,000 per year, focusing on developing robust screening technologies to enhance early detection and treatment of disorders, thereby minimizing long-term health consequences. The program is particularly important for addressing high-priority conditions where screening is not currently recommended, and it emphasizes inclusivity in research by inviting applications from a diverse range of organizations, including higher education institutions and community-based organizations. Interested applicants should note that the application deadline is November 16, 2024, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Changing Health Systems Using Evidence-based interventions to increase Colorectal Cancer Screening
    Active
    Centers for Disease Control - NCCDPHP
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Changing Health Systems Using Evidence-based Interventions to Increase Colorectal Cancer Screening." This initiative aims to partner with health systems and primary care clinics that have low colorectal cancer screening rates, focusing on implementing evidence-based interventions to enhance screening among individuals aged 45 to 75 years, particularly in populations facing barriers to screening. The program emphasizes establishing partnerships, conducting readiness assessments, and ensuring data collection to track screening processes, with an estimated total funding of $110 million available for approximately 38 awards, ranging from $350,000 to $900,000 each. Interested applicants can reach out to April Vance at 404-632-2561 or via email at abv8@cdc.gov, with applications due by January 22, 2025, and awards expected to be announced by June 12, 2025.
    Public Health Crisis Response Cooperative Agreement
    Active
    Centers for Disease Control - OPHPR
    The Centers for Disease Control and Prevention (CDC) is offering a Public Health Crisis Response Cooperative Agreement aimed at enhancing the nation's capacity to respond to public health emergencies (PHEs). This funding opportunity is specifically designed for states, political subdivisions, and other public entities that are constitutionally empowered to protect community health, with a focus on emergency preparedness and response services. The program anticipates awarding up to $500 million in total funding, with individual awards ranging from $50,000 to $5 million, and applications are due by November 19, 2024. Interested applicants can reach out to Noelle Anderson at DSLRCrisisCoag@cdc.gov for further information.
    Strengthening and Development of Sustainable Regional Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation
    Active
    Centers for Disease Control-GHC
    The Centers for Disease Control and Prevention (CDC) is forecasting a cooperative agreement opportunity titled "Strengthening and Development of Sustainable Regional Public Health and Epidemiological Workforce Capacity through Collaboration, Program Development, and Implementation." This initiative aims to enhance public health workforce (PHW) development and strengthen the capacity to prevent, detect, and respond to diseases, particularly through the Field Epidemiology Training Programs (FETP) and other workforce development programs. The program is critical in addressing public health priorities and improving surveillance systems, outbreak investigations, and disease prevention efforts at regional and country levels. The estimated total funding for this program is $75 million, with three awards expected, and applications must be submitted electronically by January 3, 2025. For further inquiries, interested applicants can contact Shana Eatman at 770.488.3933 or via email at DGHPNOFOs@cdc.gov.
    RFA-DD-18-000
    Active
    Centers for Disease Control and Prevention - ERA
    The Centers for Disease Control and Prevention (CDC) is offering a federal grant opportunity titled RFA-DD-18-000, aimed at supporting health-related initiatives through cooperative agreements. Eligible applicants include states, universities, counties, small businesses, and non-profit organizations, with the program expected to award approximately 10 grants. This funding is crucial for enhancing public health efforts, although specific funding amounts have not been disclosed. Interested parties should submit their applications by October 13, 2025, and can direct inquiries to Linton C. Browning at lbrowning@cdc.gov or by phone at 770-488-2756.